Multifactorial intervention

Multifactorial intervention has been studied in 20 papers since 2016: 7 trials and 1 observational study in people, 12 reviews; 3 in the past year. The newest paper, Nov 3, 2026: “Complication Prevention Beyond Glycaemic Control in Type 2 Diabetes: Cumulative Metabolic Exposure, Organ Vulnerability and Treatment Durability”.

Intervention

20 papers study it33 findingsUpdated

1 new paper in 30 daysSee all 20 papers on multifactorial intervention

At a glance

Independent labs found the same change in people. 11 independent labs in 7 countries.

“Short Physical Performance Battery score improved 1.58 and 1.36 points (p < .001), handgrip strength 2.84 and 2.49 kg (p < .001), functional reach 4.3 and 4.52 cm (p < .001)”
Effects of a Primary Care-Based Multifactorial Intervention on Physical and Cognitive Function in Frail, Elderly Individuals: A Randomized Controlled TrialThe journals of gerontology. Series A, Biological sciences and medical sciences2018doi:10.1093/gerona/glx259

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 11 independent labs in 7 countries
  • Funders: Instituto de Salud Carlos III and others
  • 3 of 33 findings with company ties
  • Human trial7
  • Humans1

7 studies gave multifactorial intervention to people and measured what changed.

What changedDesignPeopleSource

up: Improves liver Frailty Index

down: Decreases C-reactive protein

down: Decreases caspase-cleaved keratin 18

Randomized trial12 months37 peoplePatient cohortsBiomolecules, Nov 6, 2024

down: Prevents frailty22.1% vs. 32.8%, p = 0.013

Randomized trial36 months135 peopleBoth≥80 yearsThe oldest oldGerontology, Feb 4, 2022

down: Lowers the risk of long-term care insurance certificationHR 0.51, 95% CI 0.17-1.54; 1.8 vs 3.6 per 1,000 person-years; not statistically significant

down: Decreases long-term care costcost ratio 0.36, 95% CI 0.11-1.21, P=0.099; 375,308 vs 1,040,727 JPY cumulative

Trial32 months140 peoplecommunity-dwelling older adultsOlder adults[Nihon koshu eisei zasshi] Japanese journal of public health, Jan 1, 2020

no change: Has no effect on total direct medical costs€12,126,900 intensified vs €11,181,700 conventional

down: Decreases cost per person-year€8725 intensified vs €10,091 conventional per person-year

down: Decreases inpatient admission costs related to cardiovascular disease

Randomized trial21.2 years160 peopleIntensified vs conventional treatmentDiabetologia, Oct 6, 2018

up: Improves physical function1.58 (p <.001) at 3 months, 1.36 (p <.001) at 18 months

up: Improves cognitive function

down: Decreases number of prescriptions-9.6% vs +4.5%

Randomized trial12 weeks352 people75.3% were femalemean age 77.3 yearsCommunity-dwelling adults aged older than 65The journals of gerontology. Series A, Biological sciences and medical sciences, Jan 19, 2018

What did studies of multifactorial intervention find?

21

Studies of multifactorial intervention measured 21 outcomes, among them falls, frailty and physical function.

Falls

downin humans4RR 0.87

4 studies
  1. Multifactorial intervention decreases falls in humans (community-dwelling) (IRR 0.84, 95% CI 0.74-0.95).

    Reviewcommunity-dwellingn = 27,784

  2. Multifactorial intervention decreases falls in RAC and community settings.

    Reviewin RAC and community settings

  3. Multifactorial intervention decreases falls in humans.

    Review

  4. Multifactorial intervention decreases falls in humans (community-dwelling) (RR 0.87, 95% CI 0.80-0.95).

    Reviewcommunity-dwelling

Frailty

downin humans4

4 studies
  1. Multifactorial intervention prevents frailty in humans (22.1% vs. 32.8%, p = 0.013).

    Human trial36 monthsn = 135

  2. Multifactorial intervention decreases frailty in humans (23.9% vs. 8.2%).

    Human trial6-monthn = 200

  3. Multifactorial intervention decreases frailty in humans (Reduction of 1.0 frailty criterion (95% CI 0.4 to 1.5)).

    Human trialFrail community-dwelling people compliant with allocated treatment; complier average causal effect12 months

  4. Multifactorial intervention decreases frailty in humans (multifactorial interventions) (in 75% of studies).

    Reviewmultifactorial interventions

Physical function

upin humans2

2 studies
  1. Multifactorial intervention improves physical function in humans (1.58 (p <.001) at 3 months, 1.36 (p <.001) at 18 months).

    Human trial12 weeksn = 352

  2. Multifactorial intervention improves physical function in humans (prefrail/frail community-living elderly) (SPPB +1.58 and +1.36 points; handgrip +2.84 and +2.49 kg; functional reach +4.3 and +4.52 cm).

    Human trialprefrail/frail community-living elderly3 and 18 monthsn = 352

  3. Multifactorial intervention improves physical function in humans (multifactorial interventions) (in 58% of studies).

    Reviewmultifactorial interventions

Liver Frailty Index

upin humans2

2 studies
  1. Multifactorial intervention improves Liver Frailty Index in humans.

    Human trial12 monthsn = 10

  2. Multifactorial intervention improves liver Frailty Index in humans (compared with control group).

    Human trialcompared with control group12 months

Number of prescriptions

downin humans1

1 study
  1. Multifactorial intervention decreases number of prescriptions in humans (-9.6% vs +4.5%).

    Human trial12 weeksn = 352

  2. Multifactorial intervention decreases number of prescriptions in humans (prefrail/frail community-living elderly) (-1.39 and -1.09 prescriptions).

    Human trialprefrail/frail community-living elderly3 and 18 monthsn = 352

Isoleucine

upin humans1

1 study
  1. Multifactorial intervention increases isoleucine in humans (compared with control group).

    Human trialcompared with control group12 months

More on Isoleucine

Caspase-cleaved keratin 18

downin humans1

1 study
  1. Multifactorial intervention decreases caspase-cleaved keratin 18 in humans (compared with control group).

    Human trialcompared with control group12 months

More on Caspase-cleaved keratin 18

C-reactive protein

downin humans1

1 study
  1. Multifactorial intervention decreases C-reactive protein in humans (compared with control group).

    Human trialcompared with control group12 months

More on C-reactive protein

Long-term care cost

downin humans1

1 study
  1. Multifactorial intervention decreases long-term care cost in humans (compared with propensity-matched non-participants) (cost ratio 0.36, 95% CI 0.11-1.21, P=0.099; 375,308 vs 1,040,727 JPY cumulative).

    Human trialcompared with propensity-matched non-participantsresistance exercise, nutritional and psychosocial programs32 monthsn = 140

Inpatient admission costs related to cardiovascular disease

downin humans1

1 study
  1. Multifactorial intervention decreases inpatient admission costs related to cardiovascular disease in humans (intensified vs conventional treatment).

    Human trialintensified vs conventional treatmentintensified target-driven7.8 years intervention

Cost per person-year

downin humans1

1 study
  1. Multifactorial intervention decreases cost per person-year in humans (intensified vs conventional treatment) (€8725 intensified vs €10,091 conventional per person-year).

    Human trialintensified vs conventional treatmentintensified target-driven7.8 years intervention

Total direct medical costs

no changein humans1

1 study
  1. Multifactorial intervention showed no clear effect on total direct medical costs in humans (intensified vs conventional treatment) (€12,126,900 intensified vs €11,181,700 conventional).

    Human trialintensified vs conventional treatmentintensified target-driven21.2 years

Cognitive function

upin humans1

1 study
  1. Multifactorial intervention improves cognitive function in humans.

    Human trial12 weeksn = 352

Adherence to Mediterranean diet

upin humans1

1 study
  1. Multifactorial intervention increases adherence to Mediterranean diet in humans.

    Human trial6-monthn = 200

Functional capacity

upin humans1

1 study
  1. Multifactorial intervention improves functional capacity in humans.

    Human trial6-monthn = 200

All 21

What is multifactorial intervention linked with?

2

Studies link multifactorial intervention with 2 measures: falls and long-term care insurance certification.

Falls

downin humans1

1 study
  1. Multifactorial intervention lowers the risk of falls in humans (-11%, RR+=0.89).

    Review

Long-term care insurance certification

downin humans1HR 0.51

1 study
  1. Multifactorial intervention lowers the risk of long-term care insurance certification in humans (compared with propensity-matched non-participants) (HR 0.51, 95% CI 0.17-1.54; 1.8 vs 3.6 per 1,000 person-years; not statistically significant).

    Human trialcompared with propensity-matched non-participantsresistance exercise, nutritional and psychosocial programs32 monthsn = 140

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 13 papers in 12 months

See all 20 papers on multifactorial intervention